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Dr Mark G. Davies (Houston, Tex). Risk stratification of
patients and predictive models of outcomes are increasingly being
demanded by patients, physicians, quality management, hospitals,
and payers to direct care, assess quality, predict utilization, and
stratify levels of care. Left ventricular failure has been subdivided
into different forms, systolic pump failure (systolic dysfunction)
and diastolic filling failure (diastolic dysfunction). The current
report examines one component of ventricular dysfunction,
namely diastolic dysfunction. Prognosis of systolic dysfunction is
poor, with a 5-year survival rate of 40%, compared to 70% in
patients with isolated diastolic dysfunction. Renal insufficiency has
been shown to negatively influence survival in patients with dia-
stolic dysfunction. It seems that after open renal revascularization,
those with moderate to severe diastolic dysfunction have 50%
mortality, which suggests that an open intervention on the renals
has markedly worsened the natural history of the disease. The
manuscript does not correlate the preoperative cardiac variables of
congestive heart failure and flash pulmonary edema with diastolic
dysfunction, nor does it examine the correlation of diastolic dys-
function with accepted indices of perioperative cardiac risk. No
association with cardiac mortality or morbidity is brought out to
assist the reader in making a better determination of perioperative
risk. Last, the obvious question of the difference in outcomes
between open and percutaneous therapy is left unanswered, as is
the possible changes in diastolic dysfunction with time in the
survivors. I would like to ask the authors the following questions:
1. What was the correlation of the Lee Index and ASA grade with
diastolic dysfunction?
2. What was the cardiac morbidity and what was the correlation to
diastolic dysfunction?
3. Is this a general predictor of mortality and morbidity in all
vascular procedures?
4. Is there a difference in outcomes between open procedures and
endovascular procedures in patients with similar renal indica-
tions and diastolic dysfunction class?
5. Do you continue to offer open therapy to patients with signif-. In those patients that survived, were any follow-up echocar-
diographies performed and did any patients show an improve-
ment in diastolic function?
Dr Racheed J. Ghanami. Thank you, Dr Davies. Your first
uestion regarded ASA and the Lee Index. The Lee Index includes
reatinine, intent to perform high-risk procedure, history of coro-
ary artery disease, history of cerebrovascular disease, and history
f congestive heart failure. All of our patients underwent a high-
isk procedure. The remaining four factors were included in our
ultivariable model and none of them showed a significant rela-
ionship with survival. We do not know if the summation of these
actors as an index is significant. In regards to ASA, we had a small
roup of patients we felt would classify as 3s or 4s. The subjective
ature of that distinctionmade it hard to rely on any resulting data.
t was not included in the analysis. Your second question referred
o a potential difference in outcome in patients undergoing open
nd endovascular procedures and whether we thought this differ-
nce might help guide future therapy. We did not perform that
nalysis in this study, as all of the included patients were open renal
evascularizations. In your final question you inquired whether we
valuated these patients postoperatively for changes in the end
rgan (the heart). We did not perform follow-up echocardiogra-
hy on all subjects in our group of 76. Corriere et al19 have
reviously reported on 20 patients who were a subset of our group.
hat study evaluated both preoperative echocardiography and
-month post-renal intervention echocardiography. In that report,
here was a change in left ventricular mass index but there was no
ignificant change in the classification of the diastolic dysfunction.
here were 2 patients that had an unfavorable change in classifica-
ion of diastolic dysfunction; however, this was not statistically
ignificant for the cohort. To further investigate this question we
ave initiated 3-year follow-up echocardiographies of the same
roup of 20 patients. If there is a significant change in diastolic
unction with longer follow-up, it should be evident in these
atients.
